Furthermore, Kaplan-Meier analysis showed that HNSCC patients with lower YOD1 expression showed worse outcomes (Fig. 1D), which was reconfirmed by the Kaplan-Meier Plotter analysis of HNSCC (Fig.1E). This evidence concerns the gene YOD1 and head and neck squamous cell carcinoma.